Nitroprusside inhibits calcium-induced impairment of red blood cell deformability

Transfusion

Volumn 54, Issue 2, 2014, Pages 434-444

  Barodka, Viachaslau ^a   Mohanty, Joy G ^b   Mustafa, Asif K ^a   Santhanam, Lakshmi ^a   Nyhan, Aoibhinn ^a   Bhunia, Anil K ^a   Sikka, Gautam ^a   Nyhan, Daniel ^a   Berkowitz, Dan E ^a   Rifkind, Joseph M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCIUM; CHARYBDOTOXIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; MASS SPECTROMETRY; MOUSE; NONHUMAN;

ANIMALS; BLOOD DONORS; CALCIMYCIN; CALCIUM; CALCIUM IONOPHORES; CHARYBDOTOXIN; ENZYME INHIBITORS; ERYTHROCYTE DEFORMABILITY; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; IODOACETIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROTOXINS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; POTASSIUM;

EID: 84893980596     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12291     Document Type: Article

References (54)

1. Dejam A, Hunter CJ, Pelletier MM, Hsu LL, Machado RF, Shiva S, Power GG, Kelm M, Gladwin MT, Schechter AN,. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 2005; 106: 734-739.
2. Pawloski JR, Stamler JS,. Nitric oxide in RBCs. Transfusion 2002; 42: 1603-1609.
3. Toptas B, Baykal A, Yesilipek A, Isbir M, Kupesiz A, Yalcin O, Baskurt OK,. L-carnitine deficiency and red blood cell mechanical impairment in beta-thalassemia major. Clin Hemorheol Microcirc 2006; 35: 349-357.
4. Cicco G, Pirrelli A,. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin Hemorheol Microcirc 1999; 21: 169-177.
5. Brown CD, Ghali HS, Zhao Z, Thomas LL, Friedman EA,. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int 2005; 67: 295-300.
6. Powell RJ, Machiedo GW, Rush BF, Jr,. Decreased red blood cell deformability and impaired oxygen utilization during human sepsis. Am Surg 1993; 59: 65-68.
7. Ballas SK,. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am J Hematol 1991; 36: 122-130.
8. Schauf B, Becker S, Abele H, Klever T, Wallwiener D, Aydeniz B,. Effect of magnesium on red blood cell deformability in pregnancy. Hypertens Pregnancy 2005; 24: 17-27.
9. Almizraq R, Tchir JD, Holovati JL, Acker JP,. Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion 2013; 53: 2258-2267.
10. An X, Mohandas N,. Disorders of red cell membrane. Br J Haematol 2008; 141: 367-375.
11. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F,. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005; 15: 195-202.
12. Romero JR, Fabry ME, Suzuka S, Nagel RL, Canessa M,. Red blood cells of a transgenic mouse expressing high levels of human hemoglobin S exhibit deoxy-stimulated cation flux. J Membr Biol 1997; 159: 187-196.
13. GARDOS G,. The function of calcium in the potassium permeability of human erythrocytes. Biochim.Biophys.Acta 1958; 30: 653-654.
14. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J,. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 1997; 94: 11651-11656.
15. Tharp DL, Bowles DK,. The intermediate-conductance Ca2+-activated K+ channel (KCa3.1) in vascular disease. Cardiovasc Hematol Agents Med Chem 2009; 7: 1-11.
16. Zubair AC,. Clinical impact of blood storage lesions. Am J Hematol 2010; 85: 117-122.
17. Fergusson D, Hutton B, Hogan DL, LeBel L, Blajchman MA, Ford JC, Hebert P, Kakadekar A, Kovacs L, Lee S, Sankaran K, Shapiro S, Smyth JA, Ramesh K, Bouali NR, Tinmouth A, Walker R,. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design. Transfus Med Rev 2009; 23: 55-61.
18. Lacroix J, Hebert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, Cook D, Marshall JC, McIntyre L, Turgeon AF,. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011; 25: 197-205.
19. Steiner ME, Assmann SF, Levy JH, Marshall J, Pulkrabek S, Sloan SR, Triulzi D, Stowell CP,. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010; 43: 107-116.
20. Frank SM, Abazyan B, Ono M, Hogue CW, Cohen DB, Berkowitz DE, Ness PM, Barodka VM,. Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg 2013; 116: 975-981.
21. Schroeder RA, Kuo PC,. Nitric oxide: physiology and pharmacology. Anesth Analg 1995; 81: 1052-1059.
22. Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK,. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003; 284: H1577-H1584.
23. Nicolay JP, Liebig G, Niemoeller OM, Koka S, Ghashghaeinia M, Wieder T, Haendeler J, Busse R, Lang F,. Inhibition of suicidal erythrocyte death by nitric oxide. Pflugers Arch 2008; 456: 293-305.
24. Wang X, Sada K, Yanagi S, Yang C, Rezaul K, Yamamura H,. Intracellular calcium dependent activation of p72syk in platelets. J Biochem 1994; 116: 858-861.
25. Martina M, Kilic G, Cherubini E,. The effect of intracellular Ca2+ on GABA-activated currents in cerebellar granule cells in culture. J Membr Biol 1994; 142: 209-216.
26. Mohanty JG, Nagababu E, Friedman JS, Rifkind JM,. SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation. Exp Hematol 2013; 41: 316-321.
27. Baskurt OK, Hardeman MR, Uyuklu M, Ulker P, Cengiz M, Nemeth N, Shin S, Alexy T, Meiselman HJ,. Comparison of three commercially available ektacytometers with different shearing geometries. Biorheology 2009; 46: 251-264.
28. Morris MJ, vid-Dufilho M, Devynck MA,. Red blood cell ionized calcium concentration in spontaneous hypertension: modulation in vivo by the calcium antagonist PN 200.110. Clin Exp Pharmacol Physiol 1988; 15: 257-260.
29. Galli F, Rovidati S, Ghibelli L, Canestrari F,. S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase decreases the enzyme affinity to the erythrocyte membrane. Nitric Oxide 1998; 2: 17-27.
30. Bateman RM, Jagger JE, Sharpe MD, Ellsworth ML, Mehta S, Ellis CG,. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am J Physiol Heart Circ Physiol 2001; 280: H2848-H2856.
31. Bor-Kucukatay M, Yalcin O, Gokalp O, Kipmen-Korgun D, Yesilkaya A, Baykal A, Ispir M, Senturk UK, Kaputlu I, Baskurt OK,. Red blood cell rheological alterations in hypertension induced by chronic inhibition of nitric oxide synthesis in rats. Clin Hemorheol Microcirc 2000; 22: 267-275.
32. Korbut R, Gryglewski RJ,. Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur J Pharmacol 1993; 234: 17-22.
33. Korbut R, Gryglewski RJ,. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats. J Physiol Pharmacol 1996; 47: 591-599.
34. Mesquita R, Pires I, Saldanha C, Martins-Silva J,. Effects of acetylcholine and spermineNONOate on erythrocyte hemorheologic and oxygen carrying properties. Clin Hemorheol Microcirc 2001; 25: 153-163.
35. Starzyk D, Korbut R, Gryglewski RJ,. The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats. J Physiol Pharmacol 1997; 48: 731-735.
36. Starzyk D, Korbut R, Gryglewski RJ,. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro. J Physiol Pharmacol 1999; 50: 629-637.
37. Baskurt OK, Yalcin O, Meiselman HJ,. Hemorheology and vascular control mechanisms. Clin Hemorheol Microcirc 2004; 30: 169-178.
38. Kawano T, Zoga V, Kimura M, Liang MY, Wu HE, Gemes G, McCallum JB, Kwok WM, Hogan QH, Sarantopoulos CD,. Nitric oxide activates ATP-sensitive potassium channels in mammalian sensory neurons: action by direct S-nitrosylation. Mol Pain 2009; 5: 12.
39. Asada K, Kurokawa J, Furukawa T,. Redox-and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J Biol Chem 2009; 284: 6014-6020.
40. Tjong YW, Li M, Hung MW, Wang K, Fung ML,. Nitric oxide deficit in chronic intermittent hypoxia impairs large conductance calcium-activated potassium channel activity in rat hippocampal neurons. Free Radic Biol Med 2008; 44: 547-557.
41. Nunez L, Vaquero M, Gomez R, Caballero R, Mateos-Caceres P, Macaya C, Iriepa I, Galvez E, Lopez-Farre A, Tamargo J, Delpõn E,. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res 2006; 72: 80-89.
42. Bai CX, Takahashi K, Masumiya H, Sawanobori T, Furukawa T,. Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol 2004; 142: 567-575.
43. Baskurt OK, Yalcin O, Ozdem S, Armstrong JK, Meiselman HJ,. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 2004; 286: H222-H229.
44. Yoshida T, Inoue R, Morii T, Takahashi N, Yamamoto S, Hara Y, Tominaga M, Shimizu S, Sato Y, Mori Y,. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat Chem Biol 2006; 2: 596-607.
45. Nagababu E, Rifkind JM,. Determination of s-nitrosothiols in biological fluids by chemiluminescence. Methods Mol Biol 2011; 704: 27-37.
46. Dedkova EN, Sigova AA, Zinchenko VP,. Mechanism of action of calcium ionophores on intact cells: ionophore-resistant cells. Membr Cell Biol 2000; 13: 357-368.
47. Cordero JF, Romero PJ,. Caffeine activates a mechanosensitive Ca(2+) channel in human red cells. Cell Calcium 2002; 31: 189-200.
48. Romero PJ, Romero EA, Mateu D, Hernandez C, Fernandez I,. Voltage-dependent calcium channels in young and old human red cells. Cell Biochem Biophys 2006; 46: 265-276.
49. Soldati L, Spaventa R, Vezzoli G, Zerbi S, Adamo D, Caumo A, Rivera R, Bianchi G,. Characterization of voltage-dependent calcium influx in human erythrocytes by fura-2. Biochem Biophys Res Commun 1997; 236: 549-554.
50. Soldati L, Lombardi C, Adamo D, Terranegra A, Bianchin C, Bianchi G, Vezzoli G,. Arachidonic acid increases intracellular calcium in erythrocytes. Biochem Biophys Res Commun 2002; 293: 974-978.
51. Butler AR, Calsy Harrison AM, Glidewell C, Johnson IL,. Spectroscopic and reactivity comparison of pentacyanonitrosylruthenate(2-) with pentacyanonitrosylferrate(2-), nitroprusside. Inorganica Chim Acta 1988; 146: 187-191.
52. Butler AR, Calsy Harrison AM, Glidewell C, Sorensen PE,. The pentacyanonitrosylferrate ion. 5: The course of the reactions of nitroprusside with a range of thiols. Polyhedron 1988; 7: 1197-1202.
53. Grossi L, D'Angelo S,. Sodium nitroprusside: mechanism of NO release mediated by sulfhydryl-containing molecules. J Med Chem 2005; 48: 2622-2626.
54. Johnson MD, Wilkins RG,. Kinetics of the primary interaction of pentacyanonitrosylferrate(2-) (nitroprusside) with aliphatic thiols. Inorg Chem 1984; 23: 231-235.